1 / 12

Cluster Governance . The Example of Biocat

Cluster Governance . The Example of Biocat. Mamen Martí - Internationalisation Project Manager Communications & External Relations Department. Workshop Brazil-European Union on Cluster x C luster Cooperation Brasilia – 13th November 2012. Biocat, governance model.

mingan
Télécharger la présentation

Cluster Governance . The Example of Biocat

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ClusterGovernance. TheExample of Biocat Mamen Martí - Internationalisation Project Manager Communications & External Relations Department WorkshopBrazil-EuropeanUniononCluster x ClusterCooperation Brasilia – 13th November 2012

  2. Biocat, governance model

  3. Objectives of a cluster • Identify the assets of the BioRegion and construction of a common vision: building a sense of community • Catalyze the development of the cluster through the support of public-private agents and the synergies among them • Improve the access to critical resources : talent, funding, knowledge,… • Foster the innovation as engine for growing, mostly in traditional sectors • Foster international partnerships

  4. Our Cluster: an ecosystem for innovation

  5. Why biotechnology needs a cluster organization Biotechnology is a complex ecosystem The value chain is long and a wide variety of actors and factors are involved. This means that: • Governance systems requires the involvement of many actors • The complexity requires that the whole ecosystem has to be taken into account • Each cluster develops a different governance model

  6. MainBiotechClusters in Europe Source: CataloniaLifeSciencesReport 2011 – Ernst & Young

  7. Catalonia • 6% of theSpanishterritory • 16% of thepopulation (7M) • 19% of GDP • 21% of biotechindustry • 45% of pharma industry(Almirall, Esteve, Ferrer, Grífols, Lacer, Uriach) • 50% of themedtech sector

  8. Biocat Biocat is a private non profit foundation, founded in 2006. Its creation was fostered by both the Government of Catalonia and the Barcelona Local Council. The objective of Biocat when it was created was to enable the interactions between the public and private sectors, as well as offer the possibility of gain access to other funding programs apart from those of the Catalan Government Biocat is a small size organization that nowadays employs 19 people, whose budget is around 3 million Euros per year (1,1 of which came from regional Government) Biocat is the Catalan organization that coordinates and promotes biotechnology, biomedicine and medical technologies in Catalonia. Its mission is to boost all the agents of this environment and their initiatives, so that we have an ecosystem with strong innovation systems, active technology and knowledge transfers and an entrepreneurial business fabric that acts as economic driver of the country and contributes to society welfare. .

  9. Biocat model: actors of the ecosystem • Collaboration Entities • Catalonia • Spain • EU Clients Pharmaceutical Industry Chemical Industry Agrifood Industry Health System University BioIncubators Venture Capital Biotechnology Companies Technology Parks Testing labs, register offices Tech Transfer Offices Specialised Consulting • R&D Public Institutions • Universities • Research Centres • Hospitals • R&D Departments • Pharma Co • Fine Chemicals • Agrifood Technology Platforms Equipment Interrelation Structures Suppliers Nuclear Industry Public Administration Regional National European

  10. Composition of the trust

  11. Origin and application of funds

More Related